Annual Total Expenses
$7.28 M
-$3.02 M-29.31%
December 31, 2023
Summary
- As of February 7, 2025, TTNP annual total expenses is $7.28 million, with the most recent change of -$3.02 million (-29.31%) on December 31, 2023.
- During the last 3 years, TTNP annual total expenses has fallen by -$4.91 million (-40.29%).
- TTNP annual total expenses is now -79.14% below its all-time high of $34.90 million, reached on December 31, 2002.
Performance
TTNP Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$754.00 K
-$1.32 M-63.65%
September 30, 2024
Summary
- As of February 7, 2025, TTNP quarterly total expenses is $754.00 thousand, with the most recent change of -$1.32 million (-63.65%) on September 30, 2024.
- Over the past year, TTNP quarterly total expenses has dropped by -$1.18 million (-60.95%).
- TTNP quarterly total expenses is now -94.20% below its all-time high of $13.00 million, reached on March 31, 1997.
Performance
TTNP Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TTNP Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.3% | -61.0% |
| 3 y3 years | -40.3% | -70.3% |
| 5 y5 years | -51.1% | -72.5% |
TTNP Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.3% | at low | -71.7% | at low |
| 5 y | 5-year | -40.3% | at low | -73.5% | +112.6% |
| alltime | all time | -79.1% | +23.5% | -94.2% | +112.6% |
Titan Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $754.00 K(-63.6%) |
| Jun 2024 | - | $2.07 M(+95.1%) |
| Mar 2024 | - | $1.06 M(-45.0%) |
| Dec 2023 | $7.28 M(-29.3%) | $1.93 M(-6.3%) |
| Sep 2023 | - | $2.06 M(+29.7%) |
| Jun 2023 | - | $1.59 M(-6.4%) |
| Mar 2023 | - | $1.70 M(-36.3%) |
| Dec 2022 | $10.29 M(+7.2%) | $2.66 M(+0.6%) |
| Sep 2022 | - | $2.65 M(+8.3%) |
| Jun 2022 | - | $2.44 M(-3.8%) |
| Mar 2022 | - | $2.54 M(+2.0%) |
| Dec 2021 | $9.60 M(-21.2%) | $2.49 M(+28.0%) |
| Sep 2021 | - | $1.95 M(-19.4%) |
| Jun 2021 | - | $2.42 M(-11.9%) |
| Mar 2021 | - | $2.75 M(-3.4%) |
| Dec 2020 | $12.19 M(+16.3%) | $2.84 M(+137.7%) |
| Sep 2020 | - | $1.20 M(-28.1%) |
| Jun 2020 | - | $1.66 M(-15.8%) |
| Mar 2020 | - | $1.98 M(-133.0%) |
| Dec 2019 | $10.48 M(-29.6%) | -$5.98 M(-246.9%) |
| Sep 2019 | - | $4.07 M(-21.5%) |
| Jun 2019 | - | $5.19 M(+5.5%) |
| Mar 2019 | - | $4.92 M(+29.5%) |
| Dec 2018 | $14.88 M(+1.1%) | $3.80 M(+5.4%) |
| Sep 2018 | - | $3.60 M(+8.9%) |
| Jun 2018 | - | $3.31 M(-4.7%) |
| Mar 2018 | - | $3.47 M(+1.1%) |
| Dec 2017 | $14.72 M(+37.3%) | $3.43 M(-16.5%) |
| Sep 2017 | - | $4.11 M(+11.1%) |
| Jun 2017 | - | $3.70 M(+6.4%) |
| Mar 2017 | - | $3.48 M(+5.7%) |
| Dec 2016 | $10.72 M(+27.2%) | $3.29 M(+24.5%) |
| Sep 2016 | - | $2.64 M(-10.7%) |
| Jun 2016 | - | $2.96 M(+61.7%) |
| Mar 2016 | - | $1.83 M(-18.6%) |
| Dec 2015 | $8.43 M(+18.4%) | $2.25 M(+24.9%) |
| Sep 2015 | - | $1.80 M(-2.7%) |
| Jun 2015 | - | $1.85 M(-26.7%) |
| Mar 2015 | - | $2.53 M(+16.7%) |
| Dec 2014 | $7.12 M(-37.4%) | $2.17 M(+31.3%) |
| Sep 2014 | - | $1.65 M(+12.9%) |
| Jun 2014 | - | $1.46 M(-20.8%) |
| Mar 2014 | - | $1.84 M(+18.8%) |
| Dec 2013 | $11.37 M(-26.6%) | $1.55 M(-33.2%) |
| Sep 2013 | - | $2.33 M(-6.6%) |
| Jun 2013 | - | $2.49 M(-50.2%) |
| Mar 2013 | - | $5.00 M(+35.2%) |
| Dec 2012 | $15.49 M(+6.3%) | $3.70 M(-4.8%) |
| Sep 2012 | - | $3.88 M(+25.4%) |
| Jun 2012 | - | $3.10 M(-35.5%) |
| Mar 2012 | - | $4.80 M(+120.4%) |
| Dec 2011 | $14.57 M(-9.6%) | $2.18 M(-26.6%) |
| Sep 2011 | - | $2.97 M(-39.3%) |
| Jun 2011 | - | $4.89 M(+8.0%) |
| Mar 2011 | - | $4.53 M(-32.5%) |
| Dec 2010 | $16.12 M | $6.71 M(+79.7%) |
| Sep 2010 | - | $3.73 M(+21.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $3.07 M(+17.8%) |
| Mar 2010 | - | $2.60 M(+82.2%) |
| Dec 2009 | $5.89 M(-68.1%) | $1.43 M(-9.8%) |
| Sep 2009 | - | $1.58 M(-10.4%) |
| Jun 2009 | - | $1.77 M(+59.4%) |
| Mar 2009 | - | $1.11 M(-81.6%) |
| Sep 2008 | - | $6.02 M(-23.5%) |
| Jun 2008 | - | $7.86 M(+30.7%) |
| Mar 2008 | - | $6.01 M(-5.7%) |
| Dec 2007 | $18.46 M(+12.0%) | $6.38 M(+39.9%) |
| Sep 2007 | - | $4.56 M(+13.3%) |
| Jun 2007 | - | $4.03 M(+15.2%) |
| Mar 2007 | - | $3.49 M(0.0%) |
| Dec 2006 | $16.48 M(-28.8%) | $3.49 M(-23.2%) |
| Sep 2006 | - | $4.55 M(+25.9%) |
| Jun 2006 | - | $3.62 M(-25.0%) |
| Mar 2006 | - | $4.82 M(+12.7%) |
| Dec 2005 | $23.14 M(-9.8%) | $4.28 M(-34.6%) |
| Sep 2005 | - | $6.54 M(+11.6%) |
| Jun 2005 | - | $5.86 M(-9.3%) |
| Mar 2005 | - | $6.46 M(-10.6%) |
| Dec 2004 | $25.65 M(-6.3%) | $7.23 M(+16.1%) |
| Sep 2004 | - | $6.22 M(+8.9%) |
| Jun 2004 | - | $5.72 M(-11.8%) |
| Mar 2004 | - | $6.48 M(-5.4%) |
| Dec 2003 | $27.37 M(-21.6%) | $6.85 M(+5.4%) |
| Sep 2003 | - | $6.50 M(-7.0%) |
| Jun 2003 | - | $6.99 M(-0.5%) |
| Mar 2003 | - | $7.03 M(-25.1%) |
| Dec 2002 | $34.90 M(+21.5%) | $9.37 M(+10.1%) |
| Sep 2002 | - | $8.52 M(+2.5%) |
| Jun 2002 | - | $8.31 M(-4.4%) |
| Mar 2002 | - | $8.70 M(+2.1%) |
| Dec 2001 | $28.72 M(+38.0%) | $8.52 M(+20.5%) |
| Sep 2001 | - | $7.07 M(+7.9%) |
| Jun 2001 | - | $6.55 M(-0.5%) |
| Mar 2001 | - | $6.58 M(+7.6%) |
| Dec 2000 | $20.81 M(+70.6%) | $6.12 M(+5.1%) |
| Sep 2000 | - | $5.82 M(+46.7%) |
| Jun 2000 | - | $3.97 M(-19.0%) |
| Mar 2000 | - | $4.90 M(+44.2%) |
| Dec 1999 | $12.20 M(+6.1%) | $3.40 M(+36.0%) |
| Sep 1999 | - | $2.50 M(-21.9%) |
| Jun 1999 | - | $3.20 M(+10.3%) |
| Mar 1999 | - | $2.90 M(-14.7%) |
| Dec 1998 | $11.50 M(-54.5%) | $3.40 M(+17.2%) |
| Sep 1998 | - | $2.90 M(+16.0%) |
| Jun 1998 | - | $2.50 M(-7.4%) |
| Mar 1998 | - | $2.70 M(-34.1%) |
| Dec 1997 | $25.30 M(+132.1%) | $4.10 M(+5.1%) |
| Sep 1997 | - | $3.90 M(-7.1%) |
| Jun 1997 | - | $4.20 M(-67.7%) |
| Mar 1997 | - | $13.00 M(+233.3%) |
| Dec 1996 | $10.90 M(+14.7%) | $3.90 M(+50.0%) |
| Sep 1996 | - | $2.60 M(0.0%) |
| Jun 1996 | - | $2.60 M(+52.9%) |
| Mar 1996 | - | $1.70 M |
| Dec 1995 | $9.50 M | - |
FAQ
- What is Titan Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual total expenses year-on-year change?
- What is Titan Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly total expenses year-on-year change?
What is Titan Pharmaceuticals annual total expenses?
The current annual total expenses of TTNP is $7.28 M
What is the all time high annual total expenses for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual total expenses is $34.90 M
What is Titan Pharmaceuticals annual total expenses year-on-year change?
Over the past year, TTNP annual total expenses has changed by -$3.02 M (-29.31%)
What is Titan Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of TTNP is $754.00 K
What is the all time high quarterly total expenses for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly total expenses is $13.00 M
What is Titan Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, TTNP quarterly total expenses has changed by -$1.18 M (-60.95%)